can 503a compound tirzepatide FDA ban on compounded tirzepatide:

Author Dr Sigrid Breit from the University of Bern, Switzerland, said: "GLP-1 RAs (receptor agonists) may have antidepressant and anti-anxiety effects, potentially due to their anti-inflammatory and anti-oxidative properties, which can also help reduce neuroinflammation." GLP-1 jabs were designed to combat diabetes and are now also prescribed to help obese people lose weight

Here are the most common ones and what you can do about them

Sousa CM, Biancur DE, Wang X, et al

Both medications are glucagon-like peptide-1 receptor agonists and are used for weight management in patients with obesity

Blood sugar is stabilized, providing consistent fuel to cells